Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
BJU International
|
April 2, 2026
Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach
Jayant Siva, Can Aydogdu, Nicholas Heller, et al.
World Journal of Urology
|
October 20, 2024
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of life
Thilo Westhofen, Alexander Buchner, Simon Lennartz, et al.
European Urology Oncology
|
June 11, 2026
External Validation of the International Bladder Cancer Group Intermediate-risk Non-muscle-invasive Bladder Cancer Substratification Model
Jayant Siva, Rishi Jonnalagadda, Can Aydogdu, et al.
World Journal of Urology
|
February 10, 2025
Discrepancies between physician-assessed and patient-reported complications after cystectomy - a prospective analysis
Benedikt Ebner, Judith Hirsch, Annkathrin Holz, et al.
European Urology Open Science
|
December 3, 2025
Prospective Evaluation of Blood-based and Microbiological Early Indicators of In-hospital Infectious Complications After Open Cystectomy
Benedikt Ebner, Judith Hirsch, Annkathrin Holz, et al.
Urologia Internationalis
|
January 19, 2026
Extended versus Standard Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Cohort Study
Can Aydogdu, Florian Urban, Elena Berg, et al.
BJU International
|
July 2, 2026
Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer
Can Aydogdu, Betty Wang, Sean Thomas McSweeney, et al.
European Urology
|
June 26, 2026
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications
Can Aydogdu, Laura Bukavina, Liang Cheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2025
Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
Kim M Pabst, Sophie C Siegmund, Adrien Holzgreve, et al.
European Urology Open Science
|
July 23, 2025
Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project
Thomas Hilser, Jozefina Casuscelli, Can Aydogdu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
BJU International
|
April 2, 2026
Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach
Jayant Siva, Can Aydogdu, Nicholas Heller, et al.
World Journal of Urology
|
October 20, 2024
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of life
Thilo Westhofen, Alexander Buchner, Simon Lennartz, et al.
European Urology Oncology
|
June 11, 2026
External Validation of the International Bladder Cancer Group Intermediate-risk Non-muscle-invasive Bladder Cancer Substratification Model
Jayant Siva, Rishi Jonnalagadda, Can Aydogdu, et al.
World Journal of Urology
|
February 10, 2025
Discrepancies between physician-assessed and patient-reported complications after cystectomy - a prospective analysis
Benedikt Ebner, Judith Hirsch, Annkathrin Holz, et al.
European Urology Open Science
|
December 3, 2025
Prospective Evaluation of Blood-based and Microbiological Early Indicators of In-hospital Infectious Complications After Open Cystectomy
Benedikt Ebner, Judith Hirsch, Annkathrin Holz, et al.
Urologia Internationalis
|
January 19, 2026
Extended versus Standard Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Cohort Study
Can Aydogdu, Florian Urban, Elena Berg, et al.
BJU International
|
July 2, 2026
Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer
Can Aydogdu, Betty Wang, Sean Thomas McSweeney, et al.
European Urology
|
June 26, 2026
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications
Can Aydogdu, Laura Bukavina, Liang Cheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2025
Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
Kim M Pabst, Sophie C Siegmund, Adrien Holzgreve, et al.
European Urology Open Science
|
July 23, 2025
Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project
Thomas Hilser, Jozefina Casuscelli, Can Aydogdu, et al.
Page
of 3